Aromatase inhibitors are the standard adjuvant hormone therapy for postmenopausal women with hormone-sensitive breast cancer.
IHH Healthcare Redefines Healthcare Leadership Through Focus On Quality And Innovation. Mumbai, Maharashtra, India ; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results